Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm - 6-MTH parent results

Nov 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.01                4.28             9.10     
                                     (-20.4 pct)                  
  Operating     loss 172 mln        loss 617 mln        60 mln    
  Recurring     loss 153 mln        loss 540 mln        80 mln    
  Net              111 mln          loss 632 mln        290 mln   
  EPS             3.22 yen         loss 18.22 yen      8.36 yen   
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T

Recent news on Wakamoto Pharmaceutical

See all news